Profil
Ruggero Cadossi is the founder of IGEA SpA, where he holds the title of President since 1980.
He is currently the Chief Executive Officer at IGEA SpA Zweigniederlassung Deutschland.
Aktive Positionen von Ruggero Cadossi
| Unternehmen | Position | Beginn |
|---|---|---|
IGEA SpA
 IGEA SpA Medical SpecialtiesHealth Technology IGEA SpA is a holding company, which engages in the provision of clinical biophysics services. It develops orthopedic medical devices and oncological biophysics for the treatment of tumors. The company was founded by Ruggero Cadossi and Donata Marazzi in 1980 and is headquartered in Carpi, Italy. | Gründer | 01.01.1980 |
IGEA SpA Zweigniederlassung Deutschland
 IGEA SpA Zweigniederlassung Deutschland Medical SpecialtiesHealth Technology Part of IGEA SpA, IGEA SpA Zweigniederlassung Deutschland is a biomedical company based in Munich, Germany. The German company specializes in Orthopaedic Therapies, Oncological Therapies, and Gene Therapies. The company's products include OsteoBit® Therapy, which speeds up the repair processes of bone tissue and is indicated in the treatment of fractures, delayed union, and OsteoSpine® Therapy, which resolves pain, promotes the reabsorption of bone oedema, and speeds up fracture healing and post-operative recovery. Additionally, they offer Electrochemotherapy (ECT), which uses the principle of electroporation to treat primary and secondary solid tumours. The CEO of the company is Ruggero Cadossi. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
IGEA SpA
IGEA SpA Medical SpecialtiesHealth Technology IGEA SpA is a holding company, which engages in the provision of clinical biophysics services. It develops orthopedic medical devices and oncological biophysics for the treatment of tumors. The company was founded by Ruggero Cadossi and Donata Marazzi in 1980 and is headquartered in Carpi, Italy. | Health Technology |
IGEA SpA Zweigniederlassung Deutschland
IGEA SpA Zweigniederlassung Deutschland Medical SpecialtiesHealth Technology Part of IGEA SpA, IGEA SpA Zweigniederlassung Deutschland is a biomedical company based in Munich, Germany. The German company specializes in Orthopaedic Therapies, Oncological Therapies, and Gene Therapies. The company's products include OsteoBit® Therapy, which speeds up the repair processes of bone tissue and is indicated in the treatment of fractures, delayed union, and OsteoSpine® Therapy, which resolves pain, promotes the reabsorption of bone oedema, and speeds up fracture healing and post-operative recovery. Additionally, they offer Electrochemotherapy (ECT), which uses the principle of electroporation to treat primary and secondary solid tumours. The CEO of the company is Ruggero Cadossi. | Health Technology |
